ID   LM-MEL-59
AC   CVCL_UC58
SY   LM-Mel-59; Ludwig Melbourne-MELanoma-59
DR   ArrayExpress; E-MTAB-1496
DR   GEO; GSM2371783
DR   Wikidata; Q95982553
RX   PubMed=22102544;
RX   PubMed=22970293;
RX   PubMed=23527996;
RX   PubMed=27852308;
CC   Part of: Ludwig Institute for Cancer Research Melbourne melanoma cell line panel.
CC   HLA typing: A*11:01,24:02; B*18:01,52:01; C*07:01,12:02 (PubMed=23527996).
CC   Omics: miRNA expression profiling.
CC   Omics: Transcriptome analysis by microarray.
CC   Miscellaneous: STR profile from personal communication of Cardwell T., Olivia Newton-John Cancer Research Institute.
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 9,10
ST   D21S11: 30,32.2
ST   D5S818: 12
ST   D7S820: 9,10
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
RX   PubMed=22102544; DOI=10.1002/stem.786;
RA   Anaka M., Freyer C., Gedye C., Caballero O.L., Davis I.D., Behren A.,
RA   Cebon J.S.;
RT   "Stem cell media culture of melanoma results in the induction of a
RT   nonrepresentative neural expression profile.";
RL   Stem Cells 30:336-343(2012).
//
RX   PubMed=22970293; DOI=10.1371/journal.pone.0044707;
RA   Zhao R.Y., Mifsud N.A., Xiao K., Chan K.-F., Oveissi S., Jackson H.M.,
RA   Dimopoulos N., Guillaume P., Knights A.J., Lowen T., Robson N.C.,
RA   Russell S.E., Scotet E., Davis I.D., Maraskovsky E., Cebon J.S.,
RA   Luescher I.F., Chen W.-S.;
RT   "A novel HLA-B18 restricted CD8+ T cell epitope is efficiently
RT   cross-presented by dendritic cells from soluble tumor antigen.";
RL   PLoS ONE 7:E44707-E44707(2012).
//
RX   PubMed=23527996; DOI=10.1111/pcmr.12097;
RA   Behren A., Anaka M., Lo P.-H., Vella L.J., Davis I.D., Catimel J.,
RA   Cardwell T., Gedye C., Hudson C., Stan R., Cebon J.S.;
RT   "The Ludwig Institute for Cancer Research Melbourne melanoma cell line
RT   panel.";
RL   Pigment Cell Melanoma Res. 26:597-600(2013).
//
RX   PubMed=27852308; DOI=10.1186/s12943-016-0554-y;
RA   Andrews M.C., Cursons J., Hurley D.G., Anaka M., Cebon J.S.,
RA   Behren A., Crampin E.J.;
RT   "Systems analysis identifies miR-29b regulation of invasiveness in
RT   melanoma.";
RL   Mol. Cancer 15:72.1-72.20(2016).
//